0.7500EUR+7.76%Mkt Cap: 54.82M EURP/E: —Last update: 2026-06-01
Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echothe…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap54.82M EUR
Enterprise Value49.48M EUR
Revenue (TTM)652.00K EUR
Gross Profit-3.07M EUR
Net Income (TTM)-5.69M EUR
Revenue/Share0.0110 EUR
Last Price0.7500 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees36
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0010120402
Valuation
P/E (Trailing)—
P/E (Forward)6.96
PEG—
EV/EBITDA-6.73
EV/Revenue75.88
P/S78.03
P/B-16.19
EPS (TTM)-0.09
EPS (Forward)0.10
52W Range
0.276049% of range1.250
52W High1.250 EUR
52W Low0.2760 EUR
Profitability
Gross Margin0.00%
Oper. Margin1688.36%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-40.38%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.91M EUR
CapEx (TTM)102.00K EUR
FCF Margin-963.57%
FCF Yield-11.46%
Net Debt7.85M EUR
Net Debt/EBITDA-1.07
Balance Sheet
Debt/Equity-11369.81
Current Ratio2.79
Quick Ratio1.85
Book Value/Sh-0.0430 EUR
Cash/Share0.0570 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.73.10M
Float32.35M
Insiders55.50%
Institutions0.00%
Technical
SMA 500.4986 (+50.4%)
SMA 2000.6195 (+21.1%)
Beta0.26
S&P 52W Chg27.94%
Avg Vol (30d)210.00K
Avg Vol (10d)201.72K
Technical Indicators
RSI (14)70.1
MACD0.0346
MACD Signal0.0115
MACD Hist.+0.0231
BB Upper0.6950 EUR
BB Middle0.5382 EUR
BB Lower0.3814 EUR
BB Width58.27%
ATR (14)0.0611 EUR
Vol Ratio (20d)1.87x